Republic of Korea: Medicaments Containing Hormones Market 2025

Medicaments Containing Hormones Market Size in Republic of Korea

The South Korean medicaments containing hormones market contracted modestly to $X in 2022, dropping by X% against the previous year. Overall, consumption, however, continues to indicate a buoyant increase. As a result, consumption reached the peak level of $X. From 2020 to 2022, the growth of the market failed to regain momentum.

Medicaments Containing Hormones Production in Republic of Korea

In value terms, medicaments containing hormones production contracted slightly to $X in 2022 estimated in export price. In general, production, however, saw resilient growth. The most prominent rate of growth was recorded in 2019 when the production volume increased by X% against the previous year. As a result, production attained the peak level of $X. From 2020 to 2022, production growth failed to regain momentum.

Medicaments Containing Hormones Exports

Exports from Republic of Korea

For the third year in a row, South Korea recorded decline in shipments abroad of medicaments containing hormones but not antibiotics, which decreased by X% to X tons in 2022. In general, exports saw a abrupt slump. The pace of growth was the most pronounced in 2013 with an increase of X% against the previous year. The exports peaked at X tons in 2016; however, from 2017 to 2022, the exports failed to regain momentum.

In value terms, medicaments containing hormones exports surged to $X in 2022. Over the period under review, exports saw a abrupt downturn. The pace of growth was the most pronounced in 2014 with an increase of X%. Over the period under review, the exports attained the peak figure at $X in 2016; however, from 2017 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Indonesia (X tons) was the main destination for medicaments containing hormones exports from South Korea, with a X% share of total exports. Moreover, medicaments containing hormones exports to Indonesia exceeded the volume sent to the second major destination, Georgia (X kg), more than tenfold.

From 2012 to 2022, the average annual rate of growth in terms of volume to Indonesia amounted to X%.

In value terms, Indonesia ($X) emerged as the key foreign market for medicaments containing hormones but not antibiotics exports from South Korea, comprising X% of total exports. The second position in the ranking was held by Georgia ($X), with a X% share of total exports.

From 2012 to 2022, the average annual growth rate of value to Indonesia stood at X%.

Export Prices by Country

In 2022, the average medicaments containing hormones export price amounted to $X per ton, picking up by X% against the previous year. Overall, the export price, however, recorded a mild setback. The most prominent rate of growth was recorded in 2021 an increase of X%. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Georgia ($X per ton), while the average price for exports to Indonesia amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Georgia (X%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Hormones Imports

Imports into Republic of Korea

In 2022, the amount of medicaments containing hormones but not antibiotics imported into South Korea surged to X tons, jumping by X% compared with 2021. Over the period under review, imports, however, saw a drastic downturn. Over the period under review, imports attained the peak figure at X tons in 2012; however, from 2013 to 2022, imports remained at a lower figure.

In value terms, medicaments containing hormones imports shrank dramatically to $X in 2022. In general, imports, however, saw a abrupt downturn. The most prominent rate of growth was recorded in 2015 when imports increased by X%. Over the period under review, imports hit record highs at $X in 2012; however, from 2013 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Japan (X tons) was the main supplier of medicaments containing hormones to South Korea, with a X% share of total imports. It was followed by Taiwan (Chinese) (X kg), with a X% share of total imports.

From 2012 to 2022, the average annual growth rate of volume from Japan totaled X%.

In value terms, Japan ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to South Korea, comprising X% of total imports. The second position in the ranking was taken by Taiwan (Chinese) ($X), with a X% share of total imports.

From 2012 to 2022, the average annual rate of growth in terms of value from Japan stood at X%.

Import Prices by Country

The average medicaments containing hormones import price stood at $X per ton in 2022, waning by X% against the previous year. Over the period under review, the import price saw a abrupt curtailment. The pace of growth appeared the most rapid in 2021 when the average import price increased by X% against the previous year. As a result, import price reached the peak level of $X per ton, and then reduced notably in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Taiwan (Chinese) ($X per ton), while the price for Japan amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Taiwan (Chinese) (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :